p53 Mutations in Carcinoma of the Esophagus and Gastroesophageal Junction

REFERENCES

• Pisani P., Parkin D. M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18–29
   PubMed Web of Science ®Google Scholar
• Blot W. J., McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 1999; 26: 2–8
   PubMed Web of Science ®Google Scholar
• Jemal A., Thomas A., Murray T., Thun M. Cancer statistics 2002. CA Cancer J Clin 2002; 52(1)23–47
   PubMed Web of Science ®Google Scholar
• Gao H., Wang L. D., Zhou Q., Hong J. Y., Huang T. Y., Yang C. S. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 1994; 54(16)4342–4326
   PubMed Web of Science ®Google Scholar
• Saidi F., Sepehr A., Fahimi S., Farahvash M. J., Salehian P., Esmailzadeh A., Keshoofy M., Pirmoazen N., Yazdanbod M., Roshan M. K. Oesophageal cancer among the Turkomans of northeast Iran. Br J Cancer 2000; 83(9)1249–1254
   PubMed Web of Science ®Google Scholar
• Hollstein M. C., Peri L., Mandard A. M., Welsh J. A., Montesano R., Metcalf R. A., Bak M., Harris C. C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res 1991; 51(15)4102–4106
   PubMed Web of Science ®Google Scholar
• Munoz N., Victora C. G., Crespi M., Saul C., Braga N. M., Correa P. Hot mate drinking and precancerous lesions of the oesophagus: an endoscopic survey in southern Brazil. Int J Cancer 1987; 39(6)708–709
   PubMed Web of Science ®Google Scholar
• De Stefani E., Munoz N., Esteve J., Vassallo A., Victora C. G., Teuchmann S. Mate drinking, alcohol, tobacco, diet, and esophageal cancer in Uruguay. Cancer Res 2000; 50(2)426–431
   Google Scholar
• Daly J. M., Fry W. A., Little A. G., Winchester D. P., McKee R.F., Stewart A. K., Fremgen A. M. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 2000; 190(5)562–572
   PubMed Web of Science ®Google Scholar
• Devesa S. S., Blot W. J., Fraumeni J. F., Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83(10)2049–2053
   PubMed Web of Science ®Google Scholar
• Brown L. M., Hoover R., Silverman D., Baris D., Hayes R., Swanson G. M., Schoenberg J., Greenberg R., Liff J., Schwartz A., Dosemeci M., Pottern L., Fraumeni J. F., Jr. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 2001; 153(2)114–122
   PubMed Web of Science ®Google Scholar
• Wu A. H., Wan P., Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001; 12(8)721–732
   PubMed Web of Science ®Google Scholar
• Castellsague X., Munoz N., De Stefani E., Victora C. G., Castelletto R., Rolon P. A., Quintana M. J. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 1999; 82(5)657–664
   PubMed Web of Science ®Google Scholar
• Vaughan T. L., Davis S., Kristal A., Thomas D. B. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4(2)85–92
   PubMed Web of Science ®Google Scholar
• Lagergren J., Bergstrom R., Lindgren A., Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340(11)825–831
   PubMed Web of Science ®Google Scholar
• Romero Y., Cameron A. J., Schaid D. J., McDonnell S.K., Burgart L. J., Hardtke C. L., Murray J. A., Locke G. R., 3rd. Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol 2002; 97(5)1127–1132
   PubMed Web of Science ®Google Scholar
• Shaheen N., Ransohoff D. F. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications. JAMA 2002; 287(15)1982–1986
   PubMed Web of Science ®Google Scholar
• Montesano R., Hollstein M., Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996; 96: 225–235
   Google Scholar
• Jankowski J. A., Wright N. A., Meltzer S. J., Triadafilopoulos G., Gerboes K., Casson A. G., Kerr D., Young L. S. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154: 965–973
   PubMed Web of Science ®Google Scholar
• Wijnhoven B. P., Tilanus H. W., Dinjens W. N. Molecular biology of Barrett's adenocarcinoma. Ann Surg 2001; 233: 322–337
   PubMed Web of Science ®Google Scholar
• Hollstein M., Sidransky D., Vogelstein B., Harris C. C. P53 mutations in human cancers. Science 1991; 253(5015)49–53
   PubMed Web of Science ®Google Scholar
• Olivier M., Eeles R., Hollstein M., Khan M. A., Harris C. C., Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002; 19(6)607–614
   PubMed Web of Science ®Google Scholar
• Isobe M., Emanuel B. S., Givol D., Oren M., Croce C. M. Localization of gene for human p53 tumour antigen to band 17p13. Nature 1986; 320(6057)84–85
   PubMed Web of Science ®Google Scholar
• Lamb P., Crawford L. Characterization of the human p53 gene. Mol Cell Biol 1986; 6(5)1379–1385
   PubMed Web of Science ®Google Scholar
• Soussi T., Legros Y., Lubin R., Ory K., Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 1994; 57: 1–9
   PubMed Web of Science ®Google Scholar
• Hainaut P., Hollstein M. P53 and human cancer: The first ten thousand mutations. Adv Cancer Res 2000; 77: 81–137
   PubMed Web of Science ®Google Scholar
• Bubán T., Schmidt M., Broll R., Antal-Szalmás P., Duchrow M. Detection of mutations in the cDNA of the proliferation marker Ki-67 protein in four tumor cell lines. Cancer Genet Cytogenet 2004; 149(1)81–4
   PubMed Web of Science ®Google Scholar
• Greenblatt M. S., Bennett W. P., Hollstein M., Harris C. C. Mutations in the p53 tumor suppressor gene: clues to the cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855–4878
   PubMed Web of Science ®Google Scholar
• Taniere P., Martel-Planche G., Puttawibul P., Casson A., Montesano R., Chanvitan A., Hainaut P. Tp53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in South Thailand. Int J Cancer 2000; 88: 223–227
   PubMed Web of Science ®Google Scholar
• Kobayashi S., Koide Y., Endo M., Isono K., Ochiai T. The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability. Am J Surg 1999; 177(6)497–502
   PubMed Web of Science ®Google Scholar
• Pfeifer G. P., Denissenko M. F., Olivier M., Tretyakova N., Hecht S. S., Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002; 21: 7435–7451
   PubMed Web of Science ®Google Scholar
• Hoffmann D., Hoffmann I., El-Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol 2001; 14: 767–790
   PubMed Web of Science ®Google Scholar
• Bartsch H., Rojas M. N., Alexandrov K., Risch A. Impact of adduct determination on the assessment of cancer susceptibility. Rec Res Cancer 1998; 154: 86–96
   PubMedGoogle Scholar
• Murtaza I., Mushtaq D., Margoob M. A., Dutt A., Wani N. A., Ahmad I., Bhat M. L. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol 2006; 12(25)4033–4037
   PubMed Web of Science ®Google Scholar
• Seitz H. K., Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7: 599–612
   PubMed Web of Science ®Google Scholar
• Hu W., Feng Z., Eveleigh J., Iyer G., Pan J., Amin S., Chung F. L., Tang M. S. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 2002; 23(11)1781–1789
   PubMed Web of Science ®Google Scholar
• Goan Y. G., Chang H. C., Hsu H. K., Chou Y. P., Cheng J. T. Risk of p53 gene mutation in esophageal squamous cell carcinoma and habit of betel quid chewing in Taiwanese. Cancer Sci 2005; 96(11)758–765
   PubMed Web of Science ®Google Scholar
• Kunisaki C., Imada T., Yamada R., Hatori S., Kinbara K., Watai K., Akiyama H., Nomura M., Matsuda G., Otsuka Y., Ono H., Shimada H. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma. Hepatogastroenterol 2006; 53(69)366–371
   PubMed Web of Science ®Google Scholar
• Sodha M., Ishikawa H., Masuda N., Kato H., Miyazaki T., Nakajima M., Fukuchi M., Manda R., Fukai Y., Sakurai H., Kuwano H. Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. Int J Cancer 2004; 110(6)838–844
   PubMed Web of Science ®Google Scholar
• Poeta M. L., Manola J., Goldwasser M. A., Forestiere A., Benoit N., Califano J. A., Ridge J. A., Goodwin J., Kenady D., Saunders J., Westra W., Sidransky D., Koch W. M. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 2007; 357(25)2552–2561
   PubMed Web of Science ®Google Scholar
• Okumura H., Natsugoe S., Matsumoto M., Mataki Y., Takatori H., Ishigami S., Takao S., Aikou T. The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma. Br J Cancer 2005; 92(2)284–289
   PubMed Web of Science ®Google Scholar
• Lam K. Y., Tsao S. W., Zhang D., Law S., He D., Ma L., Wong J. Prevalence and predictive value of p53 mutation in patients with esophageal squamous cell carcinoma: a prospective clinicopathological study and survival of 70 patients. Int J Cancer 1997; 74: 212–219
   PubMed Web of Science ®Google Scholar
• Ribeiro U., Jr., Finkelstein S. D., Safatle-Ribeiro A.V., Landreneau R. J., Clarke M. R., Bakker A., Swalsky P. A., Gooding W. E., Posner M. C. P53 sequence analysis predicts treatment response and outcome of patients with esophageal cancer. Cancer 1998; 83: 7–18
   PubMed Web of Science ®Google Scholar
• Casson A. G., Evans S. C., Gillis A., Porter G. A., Veugelers P., Darnton S.j., Guernsey D. L., Hainaut P. Clinical implications of p53 tumor suppressor gene mutation protein expression in esophageal adenocarcinomas: results of a ten year prospective study. J Thorac Cardiovasc Surg 2003; 125(5)1121–1131
   PubMed Web of Science ®Google Scholar
• Ito T., Kaneko K., Makino R., Ito H., Konishi K., Kurahashi T., Kitahara T., Mitamura K. Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy. J Gastroenterol 2001; 36: 303–311
   Google Scholar
• Langer R., Von Rahden B.H., Nahrig J., Von Weyhern C., Reiter R., Feith M., Stein H. J., Siewert J. R., Hofler H., Sarbia M. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol 2006; 59(6)631–634
   PubMed Web of Science ®Google Scholar
• Puhringer-Oppermann F., Stahl M., Keller G., Sarbia M. Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction. J Cancer Res Clin Oncol 2006; 132(7)433–438
   PubMed Web of Science ®Google Scholar